Roche's Q3 Sales Rise; FY26 Outlook Affirmed

MT Newswires · 4d ago
01:30 AM EDT, 10/22/2026 (MT Newswires) -- Roche's (RO.SW) third-quarter sales increased year over year, it said Thursday. The FactSet-compiled consensus sales estimate was 15.82 billion francs. The Swiss drugmaker's sales increased 7% at constant exchange rates and 8% in Swiss francs. For full-year 2026, the group affirmed expectations for mid-single-digit growth in sales, a high single-digit rise in core EPS, and further increase in dividends in francs.